In this context, we recently found that a single-nucleotide polymorphism (SNP) 309T>G in the MDM2 promoter determines the expression of MDM2 and, in turn, modulates the recovery of patients suffering from stroke [34]. Here, MDM2 is linked to stroke disorder.